Compugen (CGEN) Return on Sales (2009 - 2026)

Compugen recorded quarterly Return on Sales of 0.04% in Q1 2026, up 12.93% quarter-over-quarter from 0.03% in Q1 2025, and little changed year-over-year from 0.04% in Q1 2025.

Compugen's Return on Sales history runs 2 years deep, the most recent figure standing at 0.04% for Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 0.00%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 0.00%
7 Evaxion A 62.56 Bn 62.54 Bn - 0.00%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 0.00%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 0.00%
10 Compugen 234.03 Mn 142.28 Mn 352,000.00 0.04%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.04%
Dec 31, 2025 0.01%
Sep 30, 2025 -0.04%
Jun 30, 2025 -0.17%
Mar 31, 2025 0.03%
Dec 31, 2024 -0.04%
Sep 30, 2024 0.01%
Jun 30, 2024 -0.02%
Mar 31, 2024 0.03%
Dec 31, 2023 0.00%
Dec 31, 2022 0.00%
Dec 31, 2020 -0.04%
Sep 30, 2018 0.00%
Dec 31, 2016 -1.60%
Sep 30, 2016 -1.11%
Jun 30, 2016 -0.13%
Mar 31, 2016 -0.95%
Dec 31, 2015 0.00%
Sep 30, 2015 -0.29%
Jun 30, 2015 -0.31%
Mar 31, 2015 -0.12%
Dec 31, 2014 0.00%
Sep 30, 2014 -0.03%
Jun 30, 2014 -0.01%
Mar 31, 2014 -0.01%
Dec 31, 2013 -0.02%
Sep 30, 2013 -0.03%
Jun 30, 2013 -1.38%
Mar 31, 2013 -0.21%
Dec 31, 2012 -0.40%
Sep 30, 2012 -0.33%
Dec 31, 2010 -0.12%
Jun 30, 2010 -0.01%
Mar 31, 2010 -0.22%
Dec 31, 2009 0.00%
Sep 30, 2009 0.00%